ebook Munafa Stock Market Course + Intraday & FNO calls  

       

STRO announcements Sutro Biopharma, Inc. announcements and dividends declared NASDAQ

Sutro Biopharma, Inc. Complete list of announcements declared & dividend announcements by Sutro Biopharma, Inc. STRO

Sutro Biopharma, Inc. STRO listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Sutro Biopharma, Inc. STRO

Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
Sutro Biopharma, Inc. (STRO) came out with quarterly earnings of [CO].42 per share, beating the Zacks Consensus Estimate of a loss of [CO].82 per share. This compares to loss of [CO].61 per share a year ago. These figures are adjusted f
Announcement as on 25 March 2024

Oppenheimer Initiates Coverage of Sutro Biopharma (STRO) with Outperform Recommendation
Fintel reports that on October 6, 2023, Oppenheimer initiated coverage of Sutro Biopharma (NASDAQ:STRO) with a Outperform recommendation.
Announcement as on 06 October 2023

JMP Securities Reiterates Sutro Biopharma (STRO) Market Outperform Recommendation
Fintel reports that on May 17, 2023, JMP Securities reiterated coverage of Sutro Biopharma (NASDAQ:STRO) with a Market Outperform recommendation.
Announcement as on 17 May 2023

HC Wainwright & Co. Reiterates Sutro Biopharma (STRO) Buy Recommendation
Fintel reports that on May 16, 2023, HC Wainwright & Co. reiterated coverage of Sutro Biopharma (NASDAQ:STRO) with a Buy recommendation.
Announcement as on 16 May 2023

Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Misses Revenue Estimates
Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of [CO].61 per share versus the Zacks Consensus Estimate of a loss of [CO].64. This compares to loss of [CO].83 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 30 March 2023

Announcements by Sutro Biopharma, Inc. first page | Next page |

STRO Sutro Biopharma, Inc. current price & indicator signals

Moving Averages for Sutro Biopharma, Inc.

  • 5Day Average: 5.65
  • 12Day Average: 2.87
  • 20Day Average: 2.06
  • 50Day Average: 1.41
  • 100Day Average: 1.14
  • 150Day Average: 1.04
  • 200Day Average: 1.02

STRO Indicators & signals

Indicator MACD (12,26,9)

4.03, 2.56, 0.53
Indicator MACD is in positive zone

Indicator ADX (14)

78.79, 73.75, 8.75
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 87
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of STRO Sutro Biopharma, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 8.66 8.48 to 9.24 -7.68% 0.17 times
04 Thu Dec 2025 9.38 7.39 to 9.38 7.82% 0.31 times
03 Wed Dec 2025 8.70 7.15 to 8.91 1091.78% 0.21 times
02 Tue Dec 2025 0.73 0.72 to 0.80 -8.75% 2.46 times
01 Mon Dec 2025 0.80 0.78 to 0.86 -13.04% 2.63 times
28 Fri Nov 2025 0.92 0.86 to 0.94 3.37% 0.26 times
26 Wed Nov 2025 0.89 0.83 to 0.91 3.49% 0.62 times
25 Tue Nov 2025 0.86 0.84 to 0.89 -2.27% 0.56 times
24 Mon Nov 2025 0.88 0.81 to 0.88 4.76% 0.85 times
21 Fri Nov 2025 0.84 0.82 to 0.87 -1.18% 0.47 times
20 Thu Nov 2025 0.85 0.83 to 0.91 -6.59% 1.65 times
19 Wed Nov 2025 0.91 0.88 to 0.95 2.25% 0.69 times

Videos related to: STRO announcements Sutro Biopharma, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

STRO announcements Sutro Biopharma, Inc. announcements and dividends declared NASDAQ

 

Back to top